Entries by Steve

Adequate Training Required to Optimize Classification of Patients With HS

Adequate bedside training sessions are necessary to optimize intrarater agreement (IAA) when classifying the skin condition hidradenitis suppurativa (HS), or acne inversa, according to a study results published in the British Journal of Dermatology. A group of researchers investigated the degree of consensus among HS raters (the interrater agreement [IEA]) and consistency of the ratings […]

ADVOCATE Trial’s Topline Data Expected to be Presented This Year

ChemoCentryx remains on track to report topline results later this year from its ongoing Phase 3 clinical trial assessing the safety and efficacy of oral avacopan (CCX168) in patients with ANCA-associated vasculitis (AAV), the company announced. Avacopan is an investigational inhibitor of the complement C5a receptor, and works by preventing the overactivation of the C5a […]

Global Hidradenitis Suppurativa Treatment Market Actual Data and Long-Term Forecasts through 2019 And 2028 GlaxoSmithKline, Johnson & Johnson, Merck

Global Hidradenitis Suppurativa Treatment Market report offers conceptual study and strategic analysis on Hidradenitis Suppurativa Treatment Industry which caters market scope, applications, topographical presence which drive the hidradenitis suppurativa treatment market.The Market size in terms of revenue (USD MN) is calculated for the study concurrently with the details of the factors affecting business growth (drivers […]

P-A-W Capital Has Cut By $400,000 Its Chemocentryx (CCXI) Position; Eminence Capital LP Has Cut By $20.19 Million Its Group 1 Automotive (GPI) Stake

P-A-W Capital Corp decreased Chemocentryx Inc (CCXI) stake by 44.44% reported in 2018Q4 SEC filing. P-A-W Capital Corp sold 40,000 shares as Chemocentryx Inc (CCXI)’s stock rose 6.99%. The P-A-W Capital Corp holds 50,000 shares with $546,000 value, down from 90,000 last quarter. Chemocentryx Inc now has $695.42 million valuation. It closed at $11.98 lastly. […]

InflaRx N.V. (IFRX) Begins Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe

FREE Breaking News Alerts from StreetInsider.com! StreetInsider.com Top Tickers, 5/14/2019 May 14, 2019 8:01 AM EDT Tweet Send to a Friend InflaRx (NASDAQ: IFRX) today announced the treatment of the first patient in IXchange, a Phase II study with IFX-1 in … This is a premium only article. To continue reading this article and more […]

As Texas Instruments (TXN) Shares Rose, Alecta Pensionsforsakring Omsesidigt Upped Position; Franklin Resources Has Lowered Its Stake in Chemocentryx (CCXI) by $631,000

Alecta Pensionsforsakring Omsesidigt increased its stake in Texas Instruments (TXN) by 54.75% based on its latest 2018Q4 regulatory filing with the SEC. Alecta Pensionsforsakring Omsesidigt bought 1.22M shares as the company’s stock rose 9.30% with the market. The institutional investor held 3.43M shares of the semiconductors company at the end of 2018Q4, valued at $322.14M, […]

Barrow Hanley Mewhinney & Strauss Continues to Hold Position in Whirlpool (WHR); As Chemocentryx (CCXI) Share Price Rose, Shareholder American Century Companies Lowered Its Position by $1.03 Million

Barrow Hanley Mewhinney & Strauss Llc increased its stake in Whirlpool Corp (WHR) by 0.57% based on its latest 2018Q4 regulatory filing with the SEC. Barrow Hanley Mewhinney & Strauss Llc bought 11,260 shares as the company’s stock rose 13.25% with the market. The institutional investor held 2.00 million shares of the consumer electronics and […]

Key companies Profile, their Market Share and other important parameters – Market Mirror

Market Scenario Market Research Future (MRFR) speculates that the global hidradenitis suppurativa market is predicted to garner USD 763.6 million, grabbing a CAGR of 4.2% during the forecast period (2017-2023). Increasing incidences of skin diseases are likely to favor the market growth to a great extent. Also known as acne inversa, hidradenitis suppurativa is referred […]